Microglia: scapegoat, saboteur, or something else?

Adriano Aguzzi1, Ben A Barres, Mariko L Bennett

  • 1Institute of Neuropathology, University Hospital Zurich, Schmelzbergstrasse 12, CH-8012 Zurich, Switzerland. adriano.aguzzi@usz.ch

Science (New York, N.Y.)
|January 12, 2013
PubMed

Insights

Microglia, the brain's immune cells, defend against neurodegenerative diseases despite often being viewed as harmful. Their dysfunction may also cause neurological diseases lacking clear immune links.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia are the primary immune cells residing in the central nervous system (CNS).
  • They perform immune surveillance and respond to CNS injury and disease.
  • Microglial activation is traditionally linked to neurotoxicity but also plays protective roles.

Purpose of the Study:

  • To explore the dual role of microglia in neurological health and disease.
  • To investigate the contribution of microglial dysfunction to neurological disorders.

Main Methods:

  • Review of existing literature on microglial function in the CNS.
  • Analysis of studies investigating microglial responses in various neurological conditions.

Main Results:

  • Microglia are crucial defenders in many neurodegenerative diseases.
  • Evidence suggests microglial dysfunction can be a primary cause of neurological diseases, even without apparent immune involvement.

Conclusions:

  • Microglia possess both neuroprotective and potentially pathogenic roles in the CNS.
  • Understanding microglial dysfunction is critical for diagnosing and treating a broader range of neurological diseases.